Amarogentin promotes osteoblast differentiation in oestrogen-deficiency-induced osteoporosis rats by modulating the Nrf-2/MAPK/ERK signalling pathway
Introduction The beneficial effect of amarogentin in the management of osteoporosis was determined using in vivo and in vitro methods. Material and methods Experimental osteoporosis was induced in rats via bilateral ovariectomy. Rats were then treated for 5 weeks with amarogentin (50 and 100 mg/kg,...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2019-11-01
|
Series: | Archives of Medical Science |
Subjects: | |
Online Access: | https://www.archivesofmedicalscience.com/Amarogentin-promotes-osteoblast-differentiation-in-oestrogen-deficiency-induced-osteoporosis,111137,0,2.html |